openPR Logo
Press release

Anti-Parkinson Drugs Market Overview

Anti-Parkinson Drugs Market

Anti-Parkinson Drugs Market

Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.

Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases, is anticipated to fuel demand for anti-parkinson drugs. Given that Parkinson's disease commonly afflicts individuals over the age of 60, the global projection indicates that by 2030, one in six individuals will be 60 or older, reaching a staggering 2.1 billion by 2050. As aging populations grow, the demand for anti-parkinson drugs is poised for substantial expansion.

Explore the Global Anti-Parkinson Drugs Market with a Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

High Prevalence of Mental Disorders as a Growth Factor:
The rising prevalence of mental health disorders is a significant driver for the anti-parkinson drugs market. Mental health disorders, characterized by substantial impairments in cognition, emotional regulation, or conduct, contribute to the growth of the anti-parkinson drug market by addressing mental disorders and providing effective treatment. As instances of mental disorders increase, the demand for anti-parkinson drugs is expected to rise accordingly.

Key Players Shaping the Market:
Major companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, and F. Hoffmann-La Roche AG play pivotal roles in steering the dynamics of the anti-parkinson drugs market. Their contributions encompass innovative products, strategic collaborations, and a focus on addressing the evolving healthcare needs associated with Parkinson's disease.

Innovative Advancements and Product Offerings:
Companies in the anti-parkinson drugs market are actively innovating products to enhance customer service. For instance, Safinamide, launched by Optimus Pharma Private Limited, serves as an anti-Parkinson drug to treat Parkinson's disease and improve patients' quality of life. Such innovations contribute to robust treatment options for Parkinson's disease, emphasizing affordability and accessibility.

Research Investment in Parkinson's Disease:
The anti-parkinson drugs market is witnessing increased investments in Parkinson's disease drug research and development (R&D). Initiatives like the $5.7 million investment by the Parkinson's Foundation in 33 projects aim to accelerate cutting-edge research on Parkinson's disease, fostering the development of novel therapies, treatments, and ultimately a cure.

Regional Insights and Market Segmentation:
North America dominates the anti-parkinson drugs market in 2023, while the Middle East is expected to emerge as the fastest-growing region.

The anti-parkinson drugs market covered in this report is segmented -
1) By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drug
2) By Route of Administration: Oral, Injection, Transdermal
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies

Access the Complete Report for In-Depth Analysis:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

Anti-Parkinson Drugs Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Anti-Parkinson Drugs Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on anti-parkinson drugs market size, anti-parkinson drugs market drivers and trends, anti-parkinson drugs market major players, competitors' revenues, market positioning, and anti-parkinson drugs market growth across geographies. The anti-parkinson drugs market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Generic Pharmaceuticals Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
Pharmaceutical Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
Branded Generics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Parkinson Drugs Market Overview here

News-ID: 3357809 • Views:

More Releases from The Business research company

Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billion by 2029
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. What Are the Dermal Regeneration Market Size Forecast for 2025? In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025? In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billion by 2029
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025? The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth? The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate

All 5 Releases


More Releases for Parkinson

Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025? The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period? The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.43 billion
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency. The firm recognised that to continue delivering high quality services to its clients it needed to provide